您的位置: 首页 > 农业专利 > 详情页

Compounds and compositions useful for the treatment of disorders associated with ntrk
专利权人:
BLUEPRINT MEDICINES CORPORATION
发明人:
JOSEPH L. KIM,NEIL BIFULCO JR.,CHANDRASEKHAR V. MIDUTURU,STEVEN MARK WENGLOWSKY
申请号:
ARP160103546
公开号:
AR106756A1
申请日:
2016.11.18
申请国别(地区):
AR
年份:
2018
代理人:
摘要:
1. Claim 1: a formula compound (1),or a pharmaceutically acceptable salt thereof, characterized in that: ring A is selected from monocyclic or bicyclic aryl, monocyclic or bicyclic heteroaryl, cycloalkyl and heterocyclyl; each RA is independently selected from monocyclic or bicyclic aryl, monocyclic or bicyclic heteroaryl, monocyclic or bicyclic cycloalkyl, monocyclic or bicyclic heterocyclyl, C₁₋₆ alkyl, C₁₋₆ alkoxy, halo, C₁₋₆ haloalkyl, C₁₋₆ haloalkoxy, C₁₋₆ hydroxyalkyl, C₁₋₆ heteroalkyl, -N (R¹) (R¹),nitro ciano -C (O) R-OC (O) R-C (O) OR-SR1,-S (O) R-S (O) -N (R) (R)- (C alquilen) -S (O) -N (R) (R)-C (O) -N (R) (R)-N (R) (R) -C (O) R-(C83218331) 832626 Aussie -N (R Erlang) -C (O) R1,-NR S (O) R-P (O) (R) (R)Y-OR1;a. Each arilo, heteromorphic, cyclopentyl, isomerized, tar, oxygen, halogenated, hydrogenated, isomerized, replaced with 0-5 grade r749191;a. Each RB from c832188331;nitro ciano y -OReach R¹ is independently selected from hydrogen, C₁₋₆ alkyl, C₁₋₆ haloalkyl, C₁₋₆ haloalkoxy, C₁₋₆ hydroxyalkyl, C₁₋₆ heteroalkyl, cycloalkyl, cycloalkylalkyl, heterocyclyl, and heterocyclylalkyl, where each of C₁₋ ₆ alkyl, C₁₋₆ haloalkyl, C₁₋₆ hydroxyalkyl, C₁₋₆ heteroalkyl, cycloalkyl, cycloalkylalkyl, heterocyclyl, and heterocyclylalkyl is independently substituted with 0-5 instances of Rᵇ;2. From hydrogen, c832131;each Rᵃ and Rᵇ is independently selected from halo, cyano, hydroxyl, C₁₋₆ alkyl, C₁₋₆ alkoxy, C₁₋₆ haloalkoxy, -N (R ’’) (R ’’),-C (O) -N (R) (R)-N (R) (R) -C (O) RY - (c832318326 lease) - n (R) - C (o) r ';each R ’and R’ ’is independently selected from hydrogen and C₁₋₆ alkyl or C₁₋₆ hydroxyalkyl; m is 0, 1, 2, 3, 4 or 5; and n is 0, 1 or 2; with the proviso that the compound is not (R) -5- (2- (2,5-difluorophenyl) pyrrolidin-1-yl) pyrazolo [1,5-a] pyrimidin-3-carbonitrile.Reivindicación 1: Un compuesto de fórmula (1), o una sal farmacéuticamente aceptable del mismo, caracterizado porque: el anillo A se selecciona entre arilo monocíclico o bicíclico, hetero
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充